Egetis Therapeutics AB (OSTO:PLED BTA) Beginning Cash Position : kr351.00 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Egetis Therapeutics AB Beginning Cash Position?

Egetis Therapeutics AB's Beginning Cash Position for the quarter that ended in Mar. 2025 was kr351.00 Mil.

Egetis Therapeutics AB's quarterly Beginning Cash Position declined from Sep. 2024 (kr192.60 Mil) to Dec. 2024 (kr128.80 Mil) but then increased from Dec. 2024 (kr128.80 Mil) to Mar. 2025 (kr351.00 Mil).

Egetis Therapeutics AB's annual Beginning Cash Position declined from Dec. 2022 (kr144.00 Mil) to Dec. 2023 (kr127.60 Mil) but then increased from Dec. 2023 (kr127.60 Mil) to Dec. 2024 (kr303.40 Mil).

Egetis Therapeutics AB Beginning Cash Position Historical Data

The historical data trend for Egetis Therapeutics AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Beginning Cash Position Chart

Egetis Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

255.10

287.90

144.00

127.60

303.40

Egetis Therapeutics AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															303.30	251.70	192.60	128.80	351.00

Egetis Therapeutics AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Egetis Therapeutics AB Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Egetis Therapeutics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:PLED BTA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

EGTX:Sweden 0ABW:UK P0F:Germany

Address

Grev Turegatan 11 C, Stockholm, SWE, 114 46

Website

https://www.egetis.com

Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines